Meet 22nd Century Group, the biotech co. driven by the mission to reduce the harm caused by smoking.
Headquartered in Buffalo, New York, 22nd Century Group is a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research.
Combined Cumulative Value of New License and Distribution Agreements Executed to Date Expected to Exceed $140 Million Over Contract Terms BUFFALO, N.Y., May 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century ...
FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd ...
MOCKSVILLE, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of ...
Repayment of $3.9 Million in Senior Secured Debt Lowers Ongoing Cash Needs and Operating Costs by Eliminating Cash Interest and Amortization Expense Company Balance Sheet Reflects Working Capital to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results